In bi-directional MR analyses, genetically predicted MS risk as exposure was not associated with BMI (Supplementary Table 33), neither with IL-6 signaling or serum IL-6 levels (Supplementary Table 34 and Supplementary Figure 6 and Supplementary Figure 7). Here, IL6 is linked to myeloid sarcoma.